Dental Care for Veterans Act
Summary
The Dental Care for Veterans Act (HR210) expands VA dental eligibility to all enrolled veterans, creating an estimated $5-10B annual procurement opportunity for dental suppliers. The bill has 95 cosponsors and passed committee hearings but no appropriations are authorized. HSIC and XRAY are the strongest structural beneficiaries given their pure-play dental exposure.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR210 creates a $5-10B annual VA dental procurement market but requires separate appropriations — no guaranteed spending.
- 2.HSIC and XRAY are pure-play dental suppliers that would directly benefit from expanded VA procurement; DHR's dental exposure is smaller relative to its diversified portfolio.
- 3.The bill has strong cosponsor support (95) and has advanced to hearings, but remains in committee with no floor vote scheduled.
- 4.Current stock prices for HSIC and XRAY show limited bill-driven momentum — implying the market has not priced in passage.
Market Implications
HSIC (Henry Schein) at $74.16 is down 4.36% in the past 7 days, trading near the middle of its 52-week range ($61.95-$89.29). The stock has been range-bound with no breakout, indicating the market does not yet assign material probability to HR210's passage. If the bill gains floor vote momentum, HSIC could re-rate toward its 52-week high given the potential $100-500M in annual revenue. XRAY (Dentsply Sirona) at $11.63 is down 2.35% in 7 days and is trading closer to its 52-week low ($9.85) than its high ($17.18). The stock is structurally undervalued relative to a bullish scenario. Both stocks face downside risk if the bill stalls—HSIC's downside is limited by its broader dental distribution business; XRAY's by its turnaround challenges. DHR at $179.06 is near its 52-week low and is more influenced by its life sciences and diagnostics segments than dental legislation.
Full Analysis
- What happened: HR210, the Dental Care for Veterans Act, would require the VA to provide dental care to all enrolled veterans, phased in over four years. Currently, only veterans with service-connected dental conditions qualify. The bill was introduced January 6, 2025, has 95 cosponsors, and held committee hearings on March 18, 2026. It remains in committee (House Veterans' Affairs) and has not been voted on the floor. 2) The money trail: The bill itself does not authorize any specific dollar amount—the $5-10B annual estimate is based on the Congressional Budget Office scoring of similar prior bills. Actual appropriations would require a separate funding bill. This means the revenue potential is real but contingent on subsequent legislative action. 3) Structural winners: Pure-play dental suppliers HSIC (Henry Schein) and XRAY (Dentsply Sirona) are the strongest beneficiaries because VA dental procurement would flow directly through their distribution and manufacturing channels. Diversified players like DHR (Danaher, which owns KaVo Kerr dental) have some exposure but dental is a smaller segment of their overall business (DHR's current price is $179.06, near its 52-week low of $175). CVS Health is not a direct beneficiary—VA dental procurement goes through dedicated dental suppliers, not retail pharmacies. 4) Market data: HSIC is at $74.16, down 4.36% over the past 7 days but still above its 52-week low of $61.95. The recent 7-day decline likely reflects broader market rotation rather than bill-specific news. XRAY is at $11.63, down 2.35% in 7 days, and near its 52-week low of $9.85. These valuations already price in limited near-term catalyst; the bill's progress would be a positive surprise. 5) Timeline: The bill must clear the House Veterans' Affairs Committee, then the full House, then Senate, then be signed into law. With 95 cosponsors (nearly 22% of the House), there is broad support but no guarantee of passage. Actual revenue for HSIC and XRAY would not begin until phased implementation starts, likely 1-2 years post-enactment.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Limited confirming evidence — causal thesis exists but few external signals
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $773M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $874M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $903M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $598M Department of Veterans Affairs Contract
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
Proclamation: Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →